Moderna announced the change Wednesday, about a week after revealing that the FDA’s vaccine chief was refusing to review the ...

Stéphane Bancel, Moderna’s chief executive officer, said that “we appreciate the FDA’s engagement in a constructive Type A meeting and its agreement to advance our application ...

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...

RFK Jr.'s attacks on vaccines go beyond changing the childhood immunization schedule. Now he's taking aim at vaccine R&D itself.

President Donald Trump will tap leader of the National Institutes of Health, Jay Bhattacharya, to also serve as acting head of Centers for Disease Control and Prevention Administrator Mehmet Oz makes ...

Officials are going after metal-containing ingredients, including aluminum adjuvants. Here’s why vaccines need them ...

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA ...

Health Secretary Robert F. Kennedy Jr. dismissed Jim O’Neill, whom Trump will nominate to lead the National Science Foundation, from the CDC job last week.

Moderna's mRNA-1010 flu vaccine for older adults could be made available by the end of 2026, the pharmaceutical company announced on Friday.

America's largest medical authority has announced it will launch a review process to 'assess safety and effectiveness' of Covid and flu vaccines, among others, ahead of next year's virus season.

Flu activity remains elevated across Tennessee, with parts of East Tennessee reporting some of the highest levels of ...

That surveillance data was the nervous system of American medicine — constantly sensing, constantly warning us what was ...